Specific immunotherapy in children: past and present.

Specific immunotherapy (SIT) in children is usually completely neglected. Pediatric SIT being not an optional treatment should be administered as soon as possible, also in children aged 2-3 years, due to the very early asthma and rhinitis onset, contrarily to a recent publication that continues to stress the danger of anaphylactic reactions without displaying reliable data. On the other hand drugs represent only a symptomatic treatment, therefore SIT is the only treatment which can alter the natural course of respiratory diseases.